VAQORASynonyms: Epitofacitinib, (3R,4S)- · (3R,4S)-Tofacitinib · (3R,4S)-(+)-Tofacitinib isomer · 3-((3R,4S)-3-((1H-Indol-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropane-nitrile
Tofacitinib Diastereomer-1 and 2 (CAS 2734856-31-4) – Tofacitinib impurity standard. C16H20N6O, MW 312.37. Vaqora Chemicals: COA, global shipping.
Tofacitinib Diastereomer-1 and 2 (CAS 2734856-31-4) is an impurity of Tofacitinib offered by Vaqora Chemicals. Formula C16H20N6O, molecular weight 312.37 g/mol. The IUPAC name is 3-[(3R,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile. Alternative names: Epitofacitinib, (3R,4S)- and (3R,4S)-Tofacitinib.
The product is provided as a solid. Store the standard in its sealed vial, protected from light and moisture, and follow the storage condition printed on the COA. Good laboratory practice and suitable PPE are recommended during handling.
This Tofacitinib impurity supports analytical method development and validation (AMV), batch release testing and the impurity sections of ANDA and DMF filings. Buyers come mainly from pharmaceutical manufacturing and academic and industrial research.
We offer Tofacitinib Diastereomer-1 and 2 in 10 mg, 25 mg, 50 mg and 100 mg packs with a batch-specific COA, and ship to customers worldwide.
View every impurity, metabolite and intermediate we list for Tofacitinib.
Tofacitinib impurities| Product name | Tofacitinib Diastereomer-1 and 2 |
|---|---|
| Catalogue No. | VQ-034310 |
| CAS Number | 2734856-31-4 |
| IUPAC name | 3-[(3R,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile |
| Molecular formula | C16H20N6O |
| Molecular weight | 312.37 g/mol |
| Exact mass | 312.1699 |
| Grade | Reference Standard |
| HSN code | 38229090 |
| InChIKey | UJLAWZDWDVHWOW-AAEUAGOBSA-N |
| SMILES | C[C@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N |
| PubChem CID | 25180101 |
| Physical form | Solid |
|---|---|
| LogP (XLogP3) | 1.5 |
| H-bond donors / acceptors | 1 / 5 |
| TPSA | 88.9 Ų |
The CAS Registry Number of Tofacitinib Diastereomer-1 and 2 is 2734856-31-4. It is also known as Epitofacitinib, (3R,4S)-, (3R,4S)-Tofacitinib, (3R,4S)-(+)-Tofacitinib isomer.
Tofacitinib Diastereomer-1 and 2 has the molecular formula C16H20N6O and a molecular weight of 312.37 g/mol. Its IUPAC name is 3-[(3R,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile.
Tofacitinib Diastereomer-1 and 2 is supplied as a characterised reference material related to Tofacitinib. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.
We supply Tofacitinib Diastereomer-1 and 2 in Reference Standard grade, in 10 mg, 25 mg, 50 mg, 100 mg packs. Larger bulk quantities and custom packing are quoted on request.
Yes. Every lot of Tofacitinib Diastereomer-1 and 2 is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.
Yes. We export Tofacitinib Diastereomer-1 and 2 worldwide by air and sea freight or express courier, on EXW, FOB, CIF, CFR or DAP Incoterms, with full export documentation.
We reply within one business day with price, pack options, lead time and documentation.
![3-((3R,4R)-3-(((5R,6S)-5,6-Dihydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile chemical structure](/media/structures/OTCVGLUFZKDIFV-QDRWXPAPSA-N.svg)
![4-Chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine chemical structure](/media/structures/LJXVPXRXXVHTBP-UHFFFAOYSA-N.svg)
![3-((3R,4R)-3-(((5S,6R)-5,6-Dihydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile chemical structure](/media/structures/OTCVGLUFZKDIFV-SUJFGCQRSA-N.svg)
![N-((3S,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure](/media/structures/UMWNXPTXDOVDFE-MAUKXSAKSA-N.svg)
![Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate chemical structure](/media/structures/IQFJFTIXSPNYQX-ZBFHGGJFSA-N.svg)
Australia
Bangladesh
Belgium
Brazil
Canada
China
Egypt
France
Germany
India
Indonesia
Ireland